Gan & Lee Pharmaceuticals to present recent data at the 57th Annual European Association for the Study of Diabetes Meeting

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is excited to present positive data from five recent abstracts which will be featured as short oral discussions at the 57th Annual European Association for the Study of Diabetes (EASD) Meeting. The meeting will be held virtually from September 27th – […]

thaipr.net

9 ก.ย. 64

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

— First participants enrolled in Phase 1 clinical trial of combination NanoFlu™/NVX–CoV2373 vaccine with Matrix-M™ adjuvant — Phase 1/2 study will evaluate immunogenicity and safety Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in a Phase 1/2 study to evaluate […]

thaipr.net

9 ก.ย. 64

RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021

– Two new analyses of Movantik® (naloxegol) data evaluated the safety and efficacy of Movantik in a subgroup of patients aged ≥ 65 years – Analysis of Movantik effects on rapid and sustained improvement of both spontaneous and complete spontaneous bowel movements in the Movantik group vs. placebo were evaluated across high and low opioid dosages – Movantik is the U.S. […]

thaipr.net

9 ก.ย. 64

Yiling Pharmaceutical’s Yishen Yangxin Anshen Tablets Granted Drug Certificate

Yiling Pharmaceutical recently announced that its newly-developed drug Yishen Yangxin Anshen Tablet had been granted official drug certificate by China’s National Medical Products Administration (NMPA). With the functions of reinforcing kidney, nourishing heart, and tranquilizing mind, this drug offers a new treatment for insomnia with the symptoms of sleeplessness, frequent dreams during sleep, palpitation, lassitude, forgetfulness,…

thaipr.net

8 ก.ย. 64

Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer

Today, Jubilant Biosys Limited announced the appointment of Giuliano Perfetti as its Chief Executive Officer. Mr. Perfetti has more than 20 years of experience across diverse businesses and global markets with expertise in Strategy, Sales, Marketing and Business Development. He has led business transformation and expansion programs working in reputed names including Accenture and Astrazeneca among […]

thaipr.net

8 ก.ย. 64

First-of-its-Kind, Global Data Repository for Interstitial Lung Diseases Launches Through Academic and Industry Collaborative

The highly-anticipated Open Source Imaging Consortium (OSIC) database is driven by global experts in pulmonology, radiology and artificial intelligence, and is the most diverse and largest for rare fibrotic lung diseases The Open Source Imaging Consortium (OSIC) today announced the launch of its global, data-rich repository of anonymized HRCT scans and clinical information regarding interstitial lung diseases (ILDs). […]

thaipr.net

8 ก.ย. 64

MIM Software Inc. Announces AI Segmentation and Single Timepoint Dosimetry Capabilities for Molecular Radiotherapy

MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy. MIM SurePlan MRT has received CE Mark approval for new artificial intelligence (AI) segmentation models, which simplify the contouring process for dosimetry. AI segmentation provides significant time savings and enhanced […]

thaipr.net

7 ก.ย. 64

JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China

The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product globally Currently the only approved CAR-T product that has been simultaneously included in the National Significant New Drug Development Program, granted priority review and breakthrough therapy designation May provide a best-in-class CAR-T therapy […]

thaipr.net

7 ก.ย. 64
1 98 99 100 101 102 128